Market Update Graphic
Source: The Market Online
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

The ASX200 has been up half a percent at 8,030 points in early afternoon trade.

Nine Entertainment (ASX:NEC) has been down around 4.6% after CEO Mike Sneesby resigned. The trouble plagued company’s share price has fallen 57% during Mr. Sneesby’s tenure and his exit ends a difficult few months.

Nine’s FY24 results reveal a 3% decline in revenue and turning the company around will be a key goal of the new CEO.

Nine has been around $1.19 and is also trading ex-dividend today.

Sectors are mostly in the green and IT has surged up around 2%, followed by Energy up around 1.75%, and Real Estate and Utilities – both up around 1%.

Company News

Clarity Pharmaceuticals Ltd (ASX:CU6) has been up around 2.5% after reporting positive results from its theranostic prostate cancer trial – known as SECURE. Data from all 3 patients indicate the drug is safe for use in high doses.  

Clarity Pharmaceuticals has been exchanged at $7.55.

AML3D (ASX:AML) has been up more than 19% on news of a license to expand delivery of 3D printed partsto the US Navy. The agreement will see the company work with key suppliers and teams within the US Navy to print, test and validate a wider range of submarine parts.

The contract is open ended and is seen by the company as a consolidation of its relationship with the US Navy.

ASL3D has been 15.5 cents.

More From The Market Online
Market concept

(Last) Market Close (of 2025): October back again as DRO, EOS & 4DX pop; otherwise mid day

If you wanted to feel like you were re-living the festivity season for the XJO that was October, look no further than today’s

EV Resources on ‘accelerated pathway’ to Los Lirios restart after strong antimony recovery tests

EV Resources is inching closer to a Los Lirios restart after strong metallurgical results set up…
Magneto scan concept

MRI scans changed medicine – what disruptive tech is next? Enter Compumedics, up +50% YoY

Compumedics, a biotech company developing its Orion Lifespan MEG product, could just be the next big…

Coles, Woolies left furious over gov’t checks designed to limit ‘excessive pricing on groceries’

Coles and Woolworths have come out swinging against the government's plan to impose stricter rules to…